Podcasts about vynamic

In this Trending Health Series, Vynamic Product Launch leaders will share their experience partnering with teams across the launch journey to provide tips and tricks for leaders to consider adopting in their next launch. For this episode, Everly, Alex, and Felice dive into how companies can establish a strong foundation for their launch by embedding launch excellence into the culture and establishing flexible frameworks to enable teams to be set up for long-term success. To learn more about how we help organizations build or maintain a culture of launch excellence, reach out to  . Please check out our other Launch Excellence Insights on the Vynamic website: Embedding Launch Excellence as a Cultural Mindset & Rethinking Launch Planning: Investing Early for Launch Success – Vynamic LLC    Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, launch excellence    Panel – Everly Petruzzelli, Alex Snopko, Felice Walter  Research & Production – Julia Morrison, Adrea Cope, Everly Petruzzelli   Recording & Editing – Mike Liberto, Rachel Skonecki    For additional discussion, please contact us at TrendingHealth.com. 

For the final installment in Vynamic's 2025 health industry outlook series, Jen is joined by Vynamic's Head of Life Sciences, Karen Baldry, and Head of Life Sciences Europe, Gemma Pfister, to focus on the Life Sciences industry – the trends most impacting the pharmaceutical and biotech sectors.To learn more about Vynamic's overall 2025 Health Industry Outlook, visit: https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, biotech, Inflation Reduction Act, product launch, direct-to-consumer, pharmacy, integrated delivery networksPanel – Karen Baldry, Gemma Pfister, Jen BurkeResearch & Production – Jen Burke, Mindy McGrathRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com.

For the second installment in Vynamic's 2025 health industry outlook series, Jen is joined by Vynamic's Head of Health Services, Ryan Hummel, and Director, Vish Kaushik, to focus on the Health Services industry – the trends most impacting providers, health plans, and pharmacy. To learn more about Vynamic's 2025 Health Industry Outlook, visit: https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/Podcast Tags: healthcare, healthcare news, health services, providers, pharmacy, PBMs, hybrid care, virtual care, value-based care, Inflation Reduction Act, AI, digital tools, next-generation medicine, drug shortages, supply chainPanel – Jen Burke, Ryan Hummel, Vish KaushikResearch & Production – Jen Burke, Mindy McGrathRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com.

When it comes to deploying AI technologies, there are both technical and ethical considerations – in healthcare, given the critical and sensitive data and decisions at play, these can be magnified nearly exponentially. Jen is joined by Vynamic's AI Mobilization Lead, Todd Quartiere, and Director, Vish Kaushik to discuss core principles and applications of responsible AI for health services organizations. To learn more about applications of responsible AI in your health services organization, check out the AI At Vynamic page for more information. Podcast Tags: healthcare, health services, responsible AI, artificial intelligence, innovation, responsible use, tech transformation, digital transformation   Panel – Todd Quartiere, Vish Kaushik, Jen Burke Research & Production – Jen Burke Recording & Editing – Mike LibertoFor additional discussion, please contact us at TrendingHealth.com.

On November 6th, Donald Trump was announced as the 47th President of the United States, returning to the White House for his second term. In this episode, Jen, Mindy, and Ryan discuss the potential changes to the healthcare industry that Republicans could look to enact over the next four years, including limiting reproductive rights and abortion access, making changes to the Affordable Care Act, and cutting funding to Medicaid. Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, reproductive rights, abortion, Affordable Care Act, Inflation Reduction Act, health insurance, Medicare, Medicaid, pharmaceuticals Source Links: Voters in Seven States Approve Constitutional Amendments to Protect Abortion Rights With a Trump Presidency, Grave Threats to Reproductive Freedoms Expected 10 Reasons a Second Trump Presidency Will Decimate Sexual and Reproductive Health What Trump's 2024 Victory Means for the Affordable Care Act  Under the Biden-Harris Administration, Over 20 Million Selected Affordable Health Coverage in ACA Marketplace Since Start of Open Enrollment Period, a Record High Millions at risk of losing health insurance after Trump's victory Fact check: Vance's promise to cover people with preexisting conditions How a Donald Trump presidency would change health care, from Medicaid to chronic disease Panel –Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Adrea Cope, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter's Pharma Customer Engagement to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic's Customer Experience Transformation Lead, Mike Zapiec, and Head of Life Sciences, Karen Baldry to share what they learned about effectively engaging customers. For more information about Vynamic's work in Customer Experience Transformation, visit: https://vynamic.com/what-we-do/services/customer-experience-transformation-cxt/ Podcast Tags: healthcare, life sciences, customer experience, omnichannel Panel – Mike Zapiec, Karen Baldry, Jen Burke Research & Production – Mike Zapiec, Karen Baldry, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026, it's clear that theorized implications from the Inflation Reduction Act are becoming realities for the life sciences industry. In this episode, Jen and Mindy are joined by Putnam Associates Partner, Scott Briggs, to explore how companies can navigate the new pricing pressures and negotiation frameworks while continuing to innovate and ensure patient access to critical therapies.For more information about Putnam's work in Value, Pricing and Access, visit their website: https://www.putassoc.com/our-expertise/value-pricing-access/For more information about Vynamic's work in Market Access, visit: https://vynamic.com/what-we-do/health-industry/life-sciences/market-access/Podcast Tags: healthcare, life sciences, product launch, market access, drug pricing, life sciences trendsPanel – Scott Briggs, Mindy McGrath, Jen BurkeResearch & Production – Scott Briggs, Mindy McGrath, Jen BurkeRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen is joined by Vynamic's Michael Hudson and Vish Kaushik to discuss a major news item that has had everyone buzzing over the last few months – ChatGPT. Podcast Tags: healthcare, healthcare news, AI, artificial intelligence, healthcare technology, health plans, providers, life sciences Source Links: Top 10 Applications of OpenAI's ChatGPT in the Healthcare Industry 5 Ways ChatGPT Will Change Healthcare Forever, For Better Transforming healthcare: the chatbot will see you now Understanding Chat-GPT, And Why It's Even Bigger Than You Think For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. Michael Hudson, Senior Director Michael.Hudson@vynamic.com Vish Kaushik, Director Vishal.Kaushik@vynamic.com Jen Burke, Healthcare Industry Strategist Jen.Burke@vynamic.com

With increasing pressure to bring products to market faster than ever, Life Sciences companies need to balance supply chain speed with global complexities, regulatory hurdles, and digital integration to maintain competitiveness. In this episode, Jen is joined by Vynamic's Dan Ahern and Roche Product Strategy Leader within Global Supply Chain, Devon Blackburn, to discuss how pharmaceutical companies are embracing change to drive launch success.Disclaimer: Devon is sharing his own opinions, which might not necessarily reflect the perspective of Roche.Podcast Tags: healthcare, life sciences, product launch, supply chain, life sciences trendsPanel – Devon Blackburn, Dan Ahern, Jen BurkeResearch & Production – Devon Blackburn, Dan Ahern, Jen BurkeRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

440: Entering the Consumer Market while Driving Sustainability with Elyse Winer CMO & GM of Consumer at GenPhoenixElyse Winer, CMO and GM of Consumer at GenPhoenix, began her career at Merrill Lynch before transitioning to healthcare consulting at Vynamic, where she gained branding and sales experience. She then moved into startups, leading marketing for Boston-based companies and collaborating with Reebok at MC10. Before joining GenPhoenix full-time, Elyse became a partner at Material Impact, a venture capital fund, where she served as interim CMO for GenPhoenix, overseeing a rebrand and their expansion into the consumer market. Her success in both startups and large companies has earned her numerous accolades, including Forbes' "30 Under 30" in Marketing & Advertising.GenPhoenix, founded in 2007 for the aviation industry, is a market leader in the mass transportation seating category, with over 250 airlines using their material. Their technology breaks down waste leather to the fiber level and uses recycled water to rebuild the fibers, creating a product even stronger than before. This recycled leather has an 86% lower carbon footprint compared to traditional leather. GenPhoenix has since expanded into the leather goods and footwear industries, collaborating with brands like Coach and Dr. Martens. To date, they have diverted more than 10,000 tons of waste from landfills.On today's show, Alan and Elyse discuss the sustainability of the fashion industry and its future direction. They explore how GenPhoenix is adapting, shifting from a predominantly B2B model to expanding into the consumer market. They also highlight partnerships with brands like Coachtopia and Dr. Martens, among others, and discuss strategies for promoting and protecting your brand in collaborations. Additionally, they discuss what early-stage companies and scale-ups, like GenPhoenix, should prioritize when allocating their marketing budgets.In this episode, you'll learn: Strategies when expanding into the consumer marketHow to protect and promote your brand in a collaborationWhat to prioritize when allocating marketing budgets, on a budgetKey Highlights: [01:37] What Snoop Dogg is like [04:36] Career path to GenPhoenix[11:00] What is GenPhoenix [14:25] What combined role of CMO and GM of Consumer looks like[18:05] Sustainability in the fashion industry[23:45] Expanding into the consumer market[27:49] How to protect your brand in a collaboration[35:22] How being budget constrained can drive creativity[40:47] Experience of your past that defines you[43:40] Advice to younger self[45:19] A topic that you and other marketers need to learn more about[47:35] Trends or subcultures others should follow[50:00] Largest opportunity or threat to marketers todayLooking for more?Visit our website for the full show notes, links to resources mentioned in this episode, and ways to connect with the guest! Become a member today and listen ad-free, visit https://plus.acast.com/s/marketingtoday. Hosted on Acast. See acast.com/privacy for more information.

Organizational AI adoption has dramatically increased over the years largely due to generative AI, leaving organizations to navigate challenges while rapidly scaling and adopting new technologies. In this episode, Jen is joined by Vynamic's Chris Wuenschel & Frank Longo, as well as AI Mobilization Offering Lead, Todd Quartiere, to discuss their experiences with different factors that can make or break AI transformation programs.To learn more about implementing AI within your organization, check out the AI At Vynamic page on Vynamic's website for more information.Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT, tech transformation, digital transformation, life sciences Source Links: The state of AI in early 2024: Gen AI adoption spikes and starts to generate value Panel – Jen Burke, Todd Quartiere, Chris Wuenschel, Frank Longo Research & Production – Everly Petruzzelli  Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In today's competitive and dynamic pharmaceutical landscape, mastering the art of brand planning and management is crucial to success. In this episode, Jen and Mindy are joined by Vynamic's Brand Strategy Offering Lead, Liza Flaherty, to discuss common challenges, best practices, and latest trends impacting the process of creating an effective brand plan.  For our listeners, if you want to learn more about Vynamic's Brand Strategy offering and brand planning capabilities, please email Liza.Flaherty@vynamic.com or visit our website for more information. Podcast Tags: healthcare, life sciences, product launch, brand planning, life sciences trends Source Links: The Essential Guide to Creating and Implementing a Successful Pharmaceutical Brand Plan Navigating the Inflation Reduction Act's Impact on Drug Pricing and Innovation The Inflation Reduction Act: the Undoing of Pharma Marketing or a Catalyst for Innovation?. Go-to-Market Strategy for Pharmaceuticals Reimagining the Brand Planning Process in Healthcare Panel – Jen Burke, Mindy McGrath, Liza Flaherty Research & Production – Liza Flaherty, Adrea Cope & Everly Petruzzelli  Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic's Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris as well as special guests, CodeScience's CEO, Mike Utell, and Chief Revenue Officer, Sean Hogan, to discuss how Life Sciences leaders should approach this decision and transition to minimize disruption and maximize business value.For more information about CodeScience, visit their website: https://www.codescience.com/For more information about Vynamic's work in Commercial Operations and Tech & Digital Transformation, visit: https://vynamic.com/ Podcast Tags: healthcare, life sciences, healthcare technology, healthcare news, Veeva, Salesforce, tech and digital transformation, CRM, commercial operations, CodeSciencePanel – Jen Burke, Jeremy Shirey, Vince Annerhed-Harris, Mike Utell, Sean HoganResearch & Production – Jen Burke, Jeremy Shirey, Vince Annerhed-HarrisRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the Supreme Court's overturning of Chevron Deference and what this will mean for the health industry, as well as strategic shifts made by Walgreens under their new CEO, and the ongoing impact of Microsoft's global IT outage on health systems, hospitals, and clinics. Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, Chevron Deference, Walgreens, pharma, pharmacy, CrowdStrike, Microsoft, IT outage Source Links: Health Care Impacts Following Chevron Decision Supreme Court overrules Chevron deference, dealing blow to federal healthcare agencies After Billions in Losses, Walgreens Doesn't Want to Own VillageMD Walgreens slashes profit guidance with plans to close more pharmacy stores, cut stake in VillageMD Impacts from global IT outage Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely available. In today's episode, Jen is joined by Vynamic's Nick Fletcher and Grace Burtonwood to shine light on the opportunities and challenges psychedelics present to the mental health market.Podcast Tags: healthcare, life sciences, healthcare news, mental health, psychedelics Source Links: WHO Topics: Mental HealthWHO Fact Sheets: Mental DisordersWHO: Global Health EstimatesMultidisciplinary Association for Psychedelic Studies (MAPS)National Institute on Drug Abuse (NIDA)Compass PathwaysBBC – FDA Advisory Committee Vote on MDMAFDA Guidance on Clinical Trials with Psychedelic DrugsHow To Change Your Mind (Michael Pollen) European Medicines Agency (EMA)Panel – Grace Burtonwood, Jen Burke, Nick Fletcher  Research & Production – Everly Petruzzelli, Nick Fletcher Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women's History Month episode, Jen is joined by Vynamic's Diana Kuritza, Jen Proietti-Fox and HelloGina's Daphne Petrich to discuss the latest trends in FemTech and what it could mean for women's health going forward. Podcast Tags: healthcare, health tech, women's health, women's history month, health equity, digital health Source Links: ·      Make 2023 the year of prioritizing women's health ·      2023 PREDICTIONS—THE GOOD, THE BAD, AND THE UGLY ·      European FemTech trends and startups to watch in 2023 | With insights from Essity Ventures ·      What To Expect for Femtech in 2023? ·      Despite 2022's headwinds, women's health startups did better than ever before ·      The dawn of the FemTech revolution ·      How FemTech is tackling the female health gap ·      Femtech's Limited Role in Tackling Healthcare Inequity For more information on HelloGina please visit, https://www.helloginahealth.com/ For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. Daphne Petrich, US Business Development Lead at HelloBetter d.petrich@hellobetter.de Jen Proietti-Fox, Director Jen.proietti-fox@vynamic.com Diana Kuritza, Manager Diana.kuritza@vynamic.com Jen Burke, Healthcare Industry Strategist Jen.Burke@vynamic.com

One of the advantages of serving clients across multiple geographies is that Vynamic can see firsthand how the differences in health systems play out in terms of spend, outcomes, and innovation. Jen & Ryan are joined by Vynamic London's Oliver White to discuss key differences between the health systems in each country and what they can learn from one another as they move healthcare delivery out of the hospital and into the community setting. In one sense, the US and UK represent two extremes on the delivery system spectrum: the US has the largest private sector system globally while the UK has the largest publicly funded system. They also differ in key metrics around healthcare spend and outcomes (01:19), science and technology (04:21), and wait times for elective procedures and emergency care (06:21). Despite these differences, both systems are focused on improving cost and customer satisfaction – especially when it comes to telehealth and home care (09:05). One model the NHS has put forward in this effort is Community Crisis Response Teams (12:38) – a model that could be attractive as US health systems look to transition care to the home and alleviate emergency department (ED) volumes (15:13). While implementing such a model could present scaling challenges in the US market (16:45), it could also offer opportunities for health plans and providers to improve quality, outcomes, and patient satisfaction (18:29). Podcast Tags: healthcare, providers, health plans, public health, NHS, CMS, telehealth, crisis care Source Links: · https://www.usnews.com/news/healthiest-communities/articles/2019-12-11/survey-finds-fragmented-us-health-care-impedes-coordination-among-providers · https://www.commonwealthfund.org/international-health-policy-center/countries/england · https://www.commonwealthfund.org/international-health-policy-center/countries/united-states · https://www.commonwealthfund.org/blog/2018/what-can-us-and-england-learn-each-others-health-care-reforms · https://www.healthcareadministration.com/brief-comparison-uk-healthcare-system-vs-u-s-healthcare-system/#:~:text=While%20both%20systems%20have%20world,tax%20based%20system%20versus%20the · https://www.england.nhs.uk/community-health-services/urgent-community-response-services/ · https://www.england.nhs.uk/wp-content/uploads/2020/11/B0252-Urgent-community-response-2-hour-and-2-days-standards-guidance-30-November-2020.pdf · https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465904/ For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. Oliver White, Director Oliver.white@vynamic.com Ryan Hummel, Executive and Head of Provider Sector ryan.hummel@vynamic.com Jen Burke, Director and Healthcare Industry Strategist jen.burke@vynamic.com

In this episode, Jen, Karan, and Ollie discuss recent newsworthy items, including the political shifts taking place across Europe and their potential impact to the pharma sector, as well as the challenges posed by medicine stockpiling and breakthroughs in hemophilia treatment.  Podcast Tags: healthcare, healthcare news, public health, Labour, pharma, medicine stockpiling, haemophilia, NHS, Novo Nordisk Source Links: With Europe facing right turn, how will public health be affected? Pharma responds to 2024 UK General Election Romanian hard-right takes healthcare on the road ahead of EU polls EU elections: a moment for pan-European health New Labour government backs pharma reform in UK Massive stockpiling of medicines increases patient risks, warns EU coalition Czechia slams Germany over drug stockpiling EU plan for medicine stockpile could worsen UK's record shortages Six EU countries push to end mandatory stockpiling of medicines Haemophilia gene therapy now available to NHS patients Novo Nordisk shares positive results for Mim8 in late-stage haemophilia A trial England, Denmark back CSL's haemophilia B gene therapy I have £2.6m blood and it has 'cured' my haemophilia Panel – Jen Burke, Karan Pandya, Ollie May Research & Production – Karan Pandya Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

The healthcare industry is in an unprecedented era of change as rapidly advancing technologies, changing consumer expectations, and rising costs force organizations to adapt. With a landscape that is becoming increasingly more competitive, organizations are facing a choice: transform traditional models of healthcare delivery or face the risk of being left behind. Today, Mindy and Jen are joined by Vynamic's Executive and Head of Health Technology Sector, Mary Virzi, to discuss this call to action and how leaders can ensure that these transformations are successful.Podcast Tags: healthcare, healthcare technology, transformations, digital transformations, healthcare transformationsSource Links: Digital Transformation in Healthcare in 2024: 7 Key Trends New Chartis survey finds that digital transformation gap is growing among health systems From belief to transformation: Digital market leaders focus on value  Top Issues Confronting Hospitals Defining your ‘true north': A road map to successful transformation Why digital transformation in healthcare is so difficult and long-overdue 2024 and beyond: Will it be economic stagnation or the advent of productivity-driven abundance? Panel – Mary Virzi, Mindy McGrath, Jen BurkeResearch & Production – Adrea Cope, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The World Health Organization (WHO) has designated climate change the top risk to global healthcare. The relationship between climate change and human health is becoming increasingly pronounced as health systems and organisations are responding to public/private sustainability initiatives to mitigate climate risks while advancing the pursuit of health equity. In this episode, Mindy and Ryan are joined by Vynamic's Ollie May to help us understand the NHS's pledge to reach Net Zero emissions and how the healthcare industry can play a leading role in promoting greener business practices. The discussion begins with understanding the definition of Net Zero and how it is relevant to the healthcare industry (1:26). The conversation transitions to explaining the NHS's carbon emission history and drivers impacting utilisation (3:27) before providing an overview of the system's Net Zero commitment (6:50) and how waste factors into these plans (10:30). The team discusses the progress to-date since the NHS published their strategies (11:35) and the impact COVID-19 has had on their plans (15:49). The U.S. Net Zero practices are also discussed (19:05) before the team wraps up by weighing the benefits and challenges of these initiatives overall (21:45). Podcast Tags: healthcare, healthcare news, Net Zero, Climate Change, NHS, COVID-19, health outcomes For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. List of Sources: https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/ https://www.england.nhs.uk/2020/10/nhs-becomes-the-worlds-national-health-system-to-commit-to-become-carbon-net-zero-backed-by-clear-deliverables-and-milestones/ Mindy McGrath, Healthcare Industry Advisor Mindy.Mcgrath@vynamic.com Ryan Hummel, Executive and Head of Provider Sector Ryan.Hummel@vynamic.com Oliver May, Director Oliver.May@vynamic.com

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the recent ruling by the United States Supreme Court on access to the abortion pill mifepristone, the declaration of bankruptcy by the Massachusetts-based Steward Health Care system, and the combination flu and COVID-19 vaccine under development by Moderna.Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, abortion, mifepristone, telemedicine, IVF, in vitro fertilization, private equity, hospitals, Steward Health Care, bankruptcy, COVID-19, flu, Moderna, mRNA, vaccines Source Links: Supreme Court rejects challenge to abortion pill accessibility The Threat to Abortion Rights You Haven't Heard of Senate Republicans block bill on women's right to IVF as Democrats make push on reproductive care Senate GOP Blocks IVF Access Bill as Democrats Press for Political Edge Steward secures funding to run its hospitals through end of June Unpacking Massachusetts' Steward health system crisis The 3rd Largest Mass Hospital system is in bankruptcy, here is what you need to know Lawmakers seek healthcare and retirement protections for Steward Health Care Workers Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shift to enhance patient interaction and outcomes.Podcast Tags: healthcare, life sciences, patient engagement, patient centricity, patient outcomes, social media, metrics, innovationDisclaimer: Nico is sharing his own opinions, which might not necessarily reflect Roche's perspectiveCheck out Nico's profile LinkedIn profile here: https://www.linkedin.com/in/nicorenner/ Source Links: Harnessing the Power of Social Media in Pharmaceutical Marketing  Pharma and Healthcare Social Media Marketing Market The Relationship Between the Pharmaceutical Industry and Social Media Intelligent Post-launch Patient Support Patient Education on Social Media is not the future… Panel – Jack Young, Nico Renner and Jen BurkeResearch & Production – Jack Young, Nico Renner and Jen BurkeRecording & Editing –Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca's announcements at ASCO, and the NHS's groundbreaking trials for personalised cancer vaccines.Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine Source Links: Summit Therapeutics, AstraZeneca And More From The Year's Biggest Cancer Conference ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation ASCO24: AstraZeneca won cancer's big meeting — again. Will that help it fulfill its $80 billion ambition? ASCO Daily Recap: AstraZeneca's hat trick, a GSK turnaround, and palliative care as telehealth At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine Moderna And Merck Advance Cancer Treatment With Promising Vaccine NHS patients in England to be offered trials for world-first cancer vaccine Thousands of cancer patients to trial personalised vaccines Panel – Jack Young, Jen Burke, Ollie May Research & Production – Jack Young, Karan Pandya Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic's Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern's Chief Experience Officer, Brian Sturgeon, to discuss how healthcare leaders can plot the course for their AI journey and prioritize their investments to better accelerate their business objectives utilizing AI tools. Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, tech transformation, digital transformation  Source Links: The AI Strategy Roadmap: Navigating the stages of value creation | The Microsoft Cloud Blog Introducing: Lantern – A Digital Innovation Consultancy Designed for the Era of AI (youtube.com) A Practical Guide to Enabling AI within your Organization. (youtube.com)   Reimagining Technology Consulting for the Era of AI – Lantern (lanternstudios.com) Panel – Jen Burke, Vince Annerhed-Harris, Brian Sturgeon Research & Production – Everly Petruzzelli, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For more information on Lantern, please visit: Lantern – Microsoft Solutions Partner (lanternstudios.com), Lantern's LinkedIn Page, Build and Modernize AI Apps – Microsoft Azure Marketplace If you want to learn more about implementing AI within your organization, you can check out Vynamic | Tech & Digital Transformation | Health Industry Consulting For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role of ride share apps in healthcare. Podcast Tags: healthcare, healthcare news, health policy, drug shortages, Medicare, hospitals, providers, FDA, telehealth, inflation reduction act, IRA, ride share, Lyft, Uber  Source Links:Senators float Medicare program that would offer incentive payments to combat drug shortages   Second House panel advances two-year telehealth extension Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits CMS proposes new mandatory organ transplant model for end-stage renal disease Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

During Fierce Life Science's MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic's Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister to share what they learned about transformation and operating with impact.To receive a copy of Vynamic's ”Operating with Impact: Topical Transformation Dilemmas and Decisions” presentation, please email gemmapfister@vynamic.com For more information about Vynamic's work in Medical Affairs, please visit https://vynamic.com/what-we-do/health-industry/life-sciences/medical-affairs/  Podcast Tags: healthcare, healthcare news, life sciences, medical affairs, MASS East, Fierce, MSL Panel – Gemma Pfister, Jen Burke, Tamaron Bertelli  Research & Production – Danielle Lewis, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe's plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week Source Links: 'Large volume' of data stolen from NHS Dumfries and Galloway published on dark web Huge volume of NHS patient and staff data released by hacker NHS cyber attack: Why stolen medical information is so much more valuable than financial data Cyber attacks are one of the biggest threats facing healthcare systems Government Launches NHS Cyber Security Strategy US tech group Palantir wins lucrative NHS data contract Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract European Commission lays down path to future-proof EU biotechnology Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies Roche agrees $7.1bn deal for Telavant to boost drug pipeline  Europe's biotech innovation in the balance Commission takes action to boost biotechnology and biomanufacturing in the EU Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis EU launches landmark €6.5M study on use of psychedelics to treat mental disorders Magic mushrooms' psilocybin can alleviate severe depression when used with therapy Psychedelic drug research held back by UK rules and attitudes, say scientists King's College Psychoactive Trials Group Panel – Jack Young, Jen Burke, Ollie May Research & Production – Karan Pandya, Jack Young Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it's become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic's Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.  To learn more about Vynamic's work in Product Launch, visit Vynamic's Product Launch page. To read more on navigating alliance product launches, see Vynamic's latest insight here.  PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.  Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trendsSource Links:Product launch challenges and how to overcome themDrug launches reflect overall company performanceTO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging CompanyRevenue of the worldwide pharmaceutical market from 2001 to 2023Prices for new US drugs rose 35% in 2023, more than the previous yearNext in pharma 2024: Reinventing for returnsThe Unbearable Cost of Drug DevelopmentUnderstanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical IndustryFDA Approves Many New Drugs in 2023 that Will Benefit Patients and ConsumersPanel – Jen Burke, Ashley Stanley, Chris Savage, Brian StammResearch & Production – Adrea Cope & Everly PetruzzelliRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the FDA approval of Rejoyn, the first prescription digital treatment for major depressive disorder. They also discuss the ongoing drug shortage crisis, as well as changes coming out of the Centers for Medicare & Medicaid Services and the impact those decisions will have over the next year.  Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, depression, mental health, digital treatment, drugs, pharmaceuticals, shortages, medications, FDA, CMS, Medicare Advantage, breakthrough technology, medical devices Source Links: FDA clears first digital treatment for depression, but experts caution that research is still early Number of ongoing US drug shortages reaches new high, pharmacist group says FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages CMS final rule on broker comp, health equity could shake up Medicare Advantage Medicare official says breakthrough device reimbursement rule coming in early summer  Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic's Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, to discuss where we see health organizations experimenting with AI and what it will take for them to achieve their long-term AI ambitions.To learn more about implementing AI within your organization, check out our recent insight: Why AI fails or flourishes: The underestimated role of culture.Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPTSource Links:The Unexpected Winners of the ChatGPT Generative AI Revolution Generative AI in healthcare: Emerging use for care US healthcare leadership: How to respond and thrive How Can AI Improve Health Care? Envisioning Healthcare in a Post-COVID-19 World Three-quarters of health professionals project widespread AI adoption 5 Key Healthcare Industry Trends to Watch in 2024 What Do We Mean When We Talk About “AI Democratisation”?  Panel – Jen Burke, Michael Hudson, Mindy McGrath, Todd QuartiereResearch & Production – Danielle Lewis, Jen BurkeRecording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity  Source Links:Dutch hospitals use AI to solve no-show patient problems that cost them millions  Cancellations of NHS care are having serious impacts on two-thirds of patients  Would charging patients for missed appointments help fund the NHS?  GP 'no shows' cost Norfolk NHS more than 1m in a one month  France planning €5 no-show fees in a bid to improve community healthcare  France divided over ‘no-show tax' for patients failing medical appointments   Researchers compile detailed catalog of bacteria living in cancer metastases  Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech  The key to young onset bowel cancer may be gut bacteria  The mystery of microbes that live inside tumours  Diversity of Bacteria in Cancer Metastases  It's the Little Things: A Role for Bacteria in Cancer Treatment   The UK is missing out on EU collaboration to improve treatment for rare diseases  Overcoming the burden of rare diseases in Europe  Stronger together in the fight against rare diseases  Is Europe on track to be the leader in rare diseases?  Right here, right now European public health policies must start giving people living with rare diseases a fair chance  New rare diseases action plan on horizon, Europe at turning point  Europe needs new 360 rare diseases strategy   Panel – Jack Young, Jen Burke, Ollie May  Research & Production – Karan Pandya  Recording & Editing – Mike Liberto, Rachel Skonecki   For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In recent years, we've seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK's Ollie May sits down with two members of Vynamic's Sustainability Council, Rosanna Vellacott and Matt O'Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations.  Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain    Source Links:  Striving for sustainable drug discovery using Green Chemistry  Accelerating the transition to net zero in life sciences  Process Digital Twin for Pharma  Sanofi harnesses Dassault's digital twin tech to optimize production at future vaccine plants  Strategies for Sustainability in the Global Pharmaceutical Supply Chain  Bayer: Improving Sustainability Practices in the Supply Chain  Bayer: Commitments in Action Creating a Sustainable Product Supply  Making biopharma's supply chains more environmentally sustainable  The pharma companies working towards supply chain sustainability  Carbon footprint of the global pharmaceutical industry and relative impact of its major players  The Greenhouse Gas Protocol: Technical Report   Understanding pharma's challenges and opportunities in relation to the climate crisis Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies  Pharma's path to Net Zero: Targeting Scope 3 emissions    Panel – Oliver May, Rosanna Vellacott, Matt O'Dell  Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May   Recording & Editing – Mike Liberto, Rachel Skonecki    For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a kidney from a CRISPR gene edited pig was transplanted into a human.Podcast Tags: healthcare, healthcare news, CVS health, PBMs, biosimilars, 340B, pharmacies, hospitals, providers, xenotransplantation, CRISPR, gene editingSource Links:As Humira biosimilars take over the market, CVS has created a new ploy; the drug “rebate credit”Federal appeals court sides with 340B contract pharmacies American Hospital Association 340B Factsheet Gene edited pig kidney transplanted into a living patient for the first timeKidney Disease Statistics for the United States Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model. Jen is joined by Vynamic's Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we've learned partnering with clients to build their omnichannel capabilities and what Life Sciences organizations can do to take their customer engagement to the next level.For more information on Vynamic's work in Customer Experience Transformation, check out our service page:  https://vynamic.com/what-we-do/services/customer-experience-transformation-cxt/ Podcast Tags: omnichannel, customer engagement, customer experience, marketing, healthcare, life sciencesPanel – Mike Zapiec, Josh Padams, Jen BurkeResearch & Production – Danielle Lewis, Hannah Yee, Aisling McAtamney, Jen BurkeRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK's Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe's mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe. Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain, supply chain Source Links: UK lacks plans to make pandemic vaccines quickly, MPs hear Spring Budget puts UK on fast-track to becoming science and technology superpower UK Spring Budget allocates funds to life sciences manufacturing £360 million to boost British manufacturing and R&D ABPI response to the Budget UK Chancellor trumpets £650m AstraZeneca investment Meet the AI chatbot therapists filling the gaps in Europe's mental health care shortfall Mental health services facing ‘vicious cycle' workforce issue A chatbot helped more people access mental-health services Closing the accessibility gap to mental health treatment with a personalized self-referral chatbot A child in Poland has to wait 238 days to see a psychiatrist, activist says From ‘crisis' to ‘pandemic': mental health in Europe Europe's mental health crisis: Which country uses the most antidepressants? Belgium leads the charge on the EU's medicines reshoring plans EU capitals propose Chips Act for medicines Onshoring and global health – has the pandemic sent globalisation into reverse? France's Emmanuel Macron seeks to relocate domestic production of key drugs to avoid shortages Barcelona identified as Europe's second-best hub for biotech investment Moderna opens international centre for analytical excellence in Madrid Spain showing great pharma potential as Barcelona named Europe's No.2 hub for biotech investment Spain Has All the Right Elements To Become a Fast-Growing Life Science Hub Spain's plan to become Europe's pharmaceutical epicentre  Panel – Jack Young, Jen Burke, Ollie MayResearch & Production – Jack Young, Karan Pandya, Ollie MayRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic's Head of Life Sciences, Karen Baldry, and Head of Health Plans, Saurabh Raman, to talk about the growth and challenges obesity medications present for the health industry.Podcast Tags: healthcare, obesity, weight loss, diabetes, health services, health plans, life sciences  Source Links: What Is Ozempic and Why Is It Getting So Much Attention? We Know Where New Weight Loss Drugs Came From, but Not Why They Work What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know Supply Updates about WegovyThe increase in appetite for obesity drugs Demand for GLP-1 drugs is growing. Here's why payers are hesitant to cover them for weight loss More than 4,000 ads for Ozempic-style drugs found running on Instagram and Facebook  Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that Cost isn't the only reason Medicare doesn't cover WegovyNew marketing push by Ozempic and others sparks body-positive backlash What You Need to Know About Compounded Versions of Popular Weight Loss Drugs Novo antes up $16.5B to poach CDMO giant Catalent amid Wegovy surge  Wegovy, other GLP-1s could lower heart disease: Study  Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics  How Ozempic and Weight Loss Drugs Are Reshaping Denmark's Economy  Novo Nordisk's Wegovy bonanza looms large in Denmark  Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion  Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect  Ozempic vs Wegovy Obesity drug boom pushes Novo Nordisk shares to record high Popular use of obesity drugs like Ozempic could change consumer habits Panel – Jen Burke, Mindy McGrath, Karen Baldry, Saurabh Raman Research & Production – Adrea Cope, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.For more perspective on the Inflation Reduction Act's impact on Life Sciences companies, check out Mindy's article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceuticalPanel – Jen Burke, Mindy McGrathResearch & Production – Jen Burke, Mindy McGrathRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama's Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new report from Reuters that revealed the dramatic increase in new drug prices throughout 2023.Podcast Tags: healthcare, healthcare news, IVF, embryos, supreme court, reproductive health, life sciences, health policy, inflation reduction act, CMS, medicare, medicaid, drug prices, pharmaceutical Source Links: The science of IVF: What to know about Alabama's 'extrauterine children' ruling : Shots - Health News : NPRRare Diseases at FDA Prices for new US drugs rose 35% in 2023, more than the previous year. Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke  Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society's push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden's pioneering use of drones in cardiac arrest intervention. Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden Source Links:We're naming cancers all wrong, oncology leader says  Forget lung, breast or prostate cancer: why tumour naming needs to change Redefining Cancer Classification: A Shift from Organ-based to Molecular-based Approach A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action Measles in Europe: WHO calls for ‘urgent' vaccinations as cases surge Europe Needs to Get on Top of Its Measles Outbreak Europe faces resurgence of measles due to low vaccination coverage Europe's first transport of blood bags by drone takes place in Belgium NHS to pioneer drone deliveries in bid to improve service Drone chemotherapy becomes an NHS net zero cancer strategy Sweden uses drones to fight cardiac arrest Healthcare From Above: Challenges And Opportunities Of Medical Drones Flight Trials for Scots Medicine-carrying Drones Conducted Government to invest £30 million in innovative technology for NHS Department of Health and Social Care: Medical Technology Strategy Drones to deliver NHS medication to care homes and GP surgeries in major roll-out NHS to begin delivering critical medical supplies by drone Panel – Jack Young, Jen Burke, Ollie MayResearch & Production – Jack Young, Karan Pandya, Ollie MayRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there's a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic's Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we've seen so far and what we can expect as 2024 kicks into gear.  Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology Source Links: The biggest stories from the 2024 J.P. Morgan Healthcare Conference 5 medtech trends to watch in 2024 MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK Medtronic aims to leverage medical device data for AI-enabled care 4 heart device trends shaping the medtech sector in 2024 J&J's Biosense Webster puts forward pulsed field ablation data showing no afib after one year Boston Scientific nets Farapulse approval, pushes back US TAVR launch J&J's Biosense Webster puts forward pulsed field ablation data showing no afib after one year Medtronic snags first pulsed field ablation approval in US Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation Increasing diabetes awareness boosts the diabetes care devices market Panel – Mary Virzi, Anila Patel, Jen Burke Research & Production – Adrea Cope, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen sits down with Vynamic's Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.Check out Vynamic's Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle. Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation Source Links: Inizio Biotech key takeaways from JPM industry event Cigna sells Medicare business to Health Care Service for $3.3 bln Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree Amazon rolls out digital health benefits program, taps Omada Health as launch partner What the Health Care Sector Was Selling at the J.P. Morgan Confab Jefferson Health says LVHN merger would double its insurance business within 2 years Panel – Jen Burke, Kevin Fletcher, Sean Martin Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and communicate the value of their work. In this deep dive episode, Jen is joined by Gemma Pfister, Head of Life Sciences Europe at Vynamic and Lori Klein, Partner, Medical & Scientific Affairs Practice Lead at Putnam, to discuss what leaders should be thinking about when it comes to measuring impact in Medical Affairs.For more information about the work Putnam does in the Medical Affairs space, visit Putnam's Medical & Scientific Affairs page. To learn more about Vynamic's work in Medical Affairs, visit Vynamic's Medical Affairs page. Podcast Tags: healthcare, life sciences, medical affairs, omnichannel, AIPanel – Gemma Pfister, Jen Burke, Lori KleinResearch & Production – Jen BurkeRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania's innovation wave in biotech and MedTech.Podcast Tags: healthcare, healthcare news, life sciences, obesity, medtech, sustainability, biotech, medtech, innovation, lithuania Source Links: Excess mortality in England post COVID-19 pandemic: implications for secondary prevention UK life expectancy falls to lowest level in a decade Excess deaths involving cardiovascular disease: an analysis Wegovy made available in the uk for weight loss in people with prediabetes and type 2 diabetes Our response to serious supply issues of drugs for people with type 2 diabetes Ministers launch £40m pilot scheme to trial wider access to slimming jab Health Inequalities, Lives, Cut Short, January 2024 Can Denmark's world-beating drugs maker stay ahead? Landmark report on reducing environmental impact of surgical care published Green Surgery – Reducing the environmental impact of surgical care Lithuania Set to Become Home to Largest Biotech City Northway Group to build $7.6bn ‘biotech city' in Lithuania Baltic-bound: is Lithuania desirable for EU life science investment? Panel – Jack Young, Jen Burke, Ollie MayResearch & Production – Jack Young, Karan Pandya, Ollie MayRecording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deriving value, expanding their business models beyond dispensing prescription drugs to become wellness destinations. Mindy and Jen are joined by Health Services Heads of Sector, Saurabh Raman and Ryan Hummel, to discuss this complex industry and its evolution. For more information about the work discussed in this episode, check out https://vynamic.com/what-we-do/health-industry/health-services/Podcast Tags: healthcare, mergers & acquisitions, pharmacy, PBMs, pharmacists, specialty pharmacy, health services  Source Links: Market Insights: Pharmacies–Worldwide  7 surprising facts about the pharmaceutical industry The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending   Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead  Competition, Consolidation, and Evolution in the Pharmacy Market  CVS Pharmacy Downsizes: 10 Industry Trends Driving the Retail Shakeout  2023 Forecast: Pharmacists push to take on a greater role in patient care  A new day in retail pharmacy: The evolving role of pharmacist  Five Trends Transforming Pharmacies into Wellness Centers of the Future  Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic An Inside Look at Walgreens' primary care and pharmacy model CVS Health completes acquisition of Oak Street Health  CVS launches new venture in biosimilar drug experiment  AMA: Don't expand scope of practice for already overworked pharmacists Panel – Jen Burke, Mindy McGrath, Ryan Hummel, Saurabh Raman Research & Production – Adrea Cope, Everly Petruzzelli, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms.Podcast Tags: healthcare, healthcare news, life sciences, mergers & acquisitions, radiopharma, medtech, artificial intelligence, antibiotics, health services, providers, private equity, hospitals Source Links: BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public ‘Explainable' AI discovers new class of antibiotics that stop MRSA in mice Discovery of a structural class of antibiotics with explainable deep learning Serious Medical Errors Rose After Private Equity Firms Bought Hospitals  Panel – Jen Burke, Mindy McGrath, Ryan Hummel Research & Production – Anna Briccetti, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy implications & judicial decisions, 2) realizing the value of convergence, 3) healthcare as a service, 4) revolutionizing healthcare through AI tech, and 5) next-gen meds.To learn more about Vynamic's 2024 health industry outlook, visit https://vynamic.com/insights/2024-health-industry-outlook/ Podcast Tags: healthcare, healthcare news, healthcare trends Panel – Jen Burke, Karen Baldry, Mary Virzi, Mindy McGrath, Ryan Hummel, Saurabh Raman Research & Production – Jen Burke, Mindy McGrath Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year's biggest health industry trends. Jen is joined by Vynamic Executive & Head of Health Technology Mary Virzi to discuss the five MedTech trends Mary expects to be most impactful in 2024. These trends include 1) increased research & development spend, 2) embracing remote patient monitoring, 3) spinoffs to expand access, 4) global regulation and policy shifts, and 5) concentrated mergers and acquisitions.To learn more about Vynamic's perspective on MedTech, visit https://vynamic.com/insights/2024-medtech-outlook/ Podcast Tags: healthcare, healthcare news, health technology, medtech, healthcare trendsPanel – Mary Virzi, Jen BurkeResearch & Production – Mary Virzi, Jen BurkeRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year's biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Life Sciences Karen Baldry to discuss the five Life Sciences trends Karen expects to be most impactful in 2024. These trends include 1) balancing innovation & affordability, 2) launching for value, 3) breaking down silos, 4) mastering omnichannel, and 5) integrating AI.To learn more about Vynamic's work in the Life Sciences sector, visit  https://vynamic.com/what-we-do/health-industry/life-sciences/ Podcast Tags: healthcare, healthcare news, life sciences, healthcare trends, healthcare innovation, product launch, omnichannel, AI  Panel – Karen Baldry, Jen Burke Research & Production – Karen Baldry, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Jen is joined by members of Vynamic's London office to unpack key insights from two recent conferences. First, Senior Executive Gemma Pfister and Director Nick Fletcher discuss the recent Evidence Life Science Medical Affairs Insights & Omnichannel Conference in London. Then, Senior Directors Jack Young and Owen Thomas cover the Next Pharma Customer Experience Summit in Vienna. Join us to stay ahead in the evolving world of omnichannel and customer experience, med affairs, and launch as our team shares expert perspectives, innovative strategies, and the latest trends shaping the Life Sciences industry. Podcast Tags: healthcare, healthcare news, life sciences, customer experience, medical affairs, omnichannel, patient centricity, digital transformation, nextpharmasummit, product launch  Source Links: From Excellent to Exceptional: The Power of Authenticity in Product Launch Evidence Life ScienceNext Pharma Summit   Panel – Gemma Pfister, Jack Young, Jen Burke, Nick Fletcher, Owen ThomasResearch & Production – Jack YoungRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year's biggest health industry trends. Jen is joined by Vynamic Executive & Head of Payers Saurabh Raman to discuss the five Payer trends Saurabh expects to be most impactful in 2024. These trends include 1) product diversification and a strategic shift to government markets, 2) regulatory changes to Medicare, 3) improving care for enrollees with social risk factors, and 4) emphasizing value and putting the patient first.To learn more about Vynamic's work with Payers in the Health Services sector, visit https://vynamic.com/what-we-do/health-industry/health-services/#payers Podcast Tags: healthcare, healthcare news, payers, health systems, health services, hospitals, healthcare trends Panel – Saurabh Raman, Jen BurkeResearch & Production – Saurabh Raman, Jen Burke Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.